UNSPSC 51385502: Salacetamide

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C9H9NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7G29CRR596, chemically known as salicylamide, n-acetyl- but generally known as salacetamide, which bears US NIH Compound Identifier 10252. European Medicines Agency schedules Salacetamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10415MIG. The term SALACETAMIDE is an International Non-Proprietary Name.

UNSPSC 51385502 Salacetamide, a Commodity code, shows minimal alignment with recent state and local procurement activity. The code's nominal scope—a topical sulfonamide pharmaceutical—does not match the single recent opportunity posted under this code: Seminole County, Florida's IFB60459723LAS, which solicits Naloxone and Safe Drug Deactivation Systems, opioid-reversal and drug-disposal products unrelated to salacetamide. This mismatch suggests either a coding error in the source record or a jurisdiction's use of an inaccurate UNSPSC tag. The procurement does reflect genuine state and local demand for harm-reduction and public-health products, with quarterly delivery cycles and fixed-fee pricing models, but the opportunity itself does not represent typical activity under the salacetamide code.

Seminole County posted the Naloxone and Drug Deactivation Systems solicitation on June 30, 2026, with a response deadline of July 26, 2023—a date conflict in the source that renders the timeline unclear. The county seeks 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding, with delivery to the Seminole County Community Health Building in Sanford, Florida. Bidders must include all shipping and delivery costs in their proposals, maintain workers' compensation and general liability insurance, comply with E-Verify and drug-free workplace requirements, and accept a three-month probationary termination clause. The contract carries a two-year initial term with a one-year renewal option and is potentially FEMA-funded. No explicit disadvantaged-enterprise set-asides are noted. The code shows no other recent state and local opportunities and does not support a clear signal of active procurement volume under the salacetamide Commodity classification.